Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 106NIH 40INDUSTRY 29NETWORK 24OTHER_GOV 4UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymoma 1Thoracic Neoplasms 1Stomach Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Pain 1Neutropenia 1Neoplasms by Site 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Gastric Adenocarcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Ductal, Breast 1Carcinoma 1Cancer Pain 1Breast Diseases 1

Interventions

Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Colonic Neoplasms × Clear all
NCT05074966 2021-10-12

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

ChineseAMS

Phase 3 Unknown
314 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡